Literature DB >> 21882114

Ethical considerations in conducting pediatric research.

Michelle Roth-Cline1, Jason Gerson, Patricia Bright, Catherine S Lee, Robert M Nelson.   

Abstract

The critical need for pediatric research on drugs and biological products underscores the responsibility to ensure that children are enrolled in clinical research that is both scientifically necessary and ethically sound. In this chapter, we review key ethical considerations concerning the participation of children in clinical research. We propose a basic ethical framework to guide pediatric research, and suggest how this framework might be operationalized in linking science and ethics. Topics examined include: the status of children as a vulnerable population; the appropriate balance of risk and potential benefit in research; ethical considerations underlying study design, including clinical equipoise, placebo controls, and non-inferiority designs; the use of data monitoring committees; compensation; and parental permission and child assent to participate in research. We incorporate selected national (USA) and international guidelines, as well as regulatory approaches to pediatric studies that have been adopted in the USA, Canada, and Europe.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21882114     DOI: 10.1007/978-3-642-20195-0_11

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  12 in total

1.  Biopharmaceutic planning in pediatric drug development.

Authors:  Vivek S Purohit
Journal:  AAPS J       Date:  2012-05-05       Impact factor: 4.009

2.  Meeting the goal of concurrent adolescent and adult licensure of HIV prevention and treatment strategies.

Authors:  Michelle Hume; Linda L Lewis; Robert M Nelson
Journal:  J Med Ethics       Date:  2017-05-15       Impact factor: 2.903

Review 3.  Molecularly Targeted Agents in the Therapy of Pediatric Brain Tumors.

Authors:  Miriam Bornhorst; Eugene I Hwang
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

4.  Spinal Muscular Atrophy Type I: Is It Ethical to Standardize Supportive Care Intervention in Clinical Trials?

Authors:  Richard S Finkel; Kathie M Bishop; Robert M Nelson
Journal:  J Child Neurol       Date:  2016-10-22       Impact factor: 1.987

Review 5.  Ethics review of pediatric multi-center drug trials.

Authors:  Allison C Needham; Mufiza Z Kapadia; Martin Offringa
Journal:  Paediatr Drugs       Date:  2015-02       Impact factor: 3.022

Review 6.  Ethical issues in neonatal and pediatric clinical trials.

Authors:  Naomi Laventhal; Beth A Tarini; John Lantos
Journal:  Pediatr Clin North Am       Date:  2012-08-26       Impact factor: 3.278

7.  Promoting education, mentorship, and support for pediatric research.

Authors: 
Journal:  Pediatrics       Date:  2014-05       Impact factor: 7.124

8.  Thank you for your lovely card: ethical considerations in responding to bereaved parents invited in error to participate in childhood cancer survivorship research.

Authors:  Claire E Wakefield; Jordana K McLoone; Leigh A Donovan; Richard J Cohn
Journal:  Med Health Care Philos       Date:  2015-02

Review 9.  Pharmacokinetic studies in children: recommendations for practice and research.

Authors:  Charlotte I S Barker; Joseph F Standing; Lauren E Kelly; Lauren Hanly Faught; Allison C Needham; Michael J Rieder; Saskia N de Wildt; Martin Offringa
Journal:  Arch Dis Child       Date:  2018-04-19       Impact factor: 3.791

10.  Parents' perceived obstacles to pediatric clinical trial participation: Findings from the clinical trials transformation initiative.

Authors:  Rachel G Greenberg; Breck Gamel; Diane Bloom; John Bradley; Hasan S Jafri; Denise Hinton; Sumathi Nambiar; Chris Wheeler; Rosemary Tiernan; P Brian Smith; Jamie Roberts; Daniel K Benjamin
Journal:  Contemp Clin Trials Commun       Date:  2017-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.